Skip to content
777 Sourcing.

Capability

non-GLP toxicity studies

Suppliers
2
States & provinces
2
Countries
1

2 non-glp toxicity studies suppliers across 2 states and provinces in 1 country. Profiles show capabilities, materials, certifications, and facility locations so you can compare shops and build a shortlist.

Suppliers

BIOCYTOGEN BOSTON CORP

WALTHAM, MA

Biocytogen is a global provider of animal and cell model generation for preclinical research, offering gene-edited and humanized mouse models, cell lines, and integrated drug discovery services. Through its BioMice brand it supplies off-the-shelf and custom animal models, and it develops fully human antibody discovery platforms including the RenMice family (RenMab, RenLite, RenNano, RenTCRmimic, RenMice KO) based on its SUPCE gene-editing technology.

antibody discoverycolony management and breedingcryopreservationgene editinghumanized mouse modelsin vitro pharmacologyin vivo pharmacologyknockout/knockin mouse model generationPK/PD studiesrederivation

Compiled from public sources

DAUNTLESS BIOTHERAPEUTICS, INC.

SAN DIEGO, CA

Dauntless Biotherapeutics is a private preclinical oncology company led and advised by a team of researchers and industry veterans. It is developing an Antibody Drug Conjugate (ADC) to an undisclosed Tumor Associated Antigen (TAA) to treat cancers of unmet need, and is conducting a seed round to raise capital for lead optimization, in vivo, and non-GLP toxicity studies in preparation of an IND filing.

IND filing preparationin vivo studieslead optimization

Compiled from public sources

Related capabilities

Other processes offered by the shops that list non-GLP toxicity studies.

Browse all capabilities